Rheinmetall's stock has dropped to a 52-week low, down 48% from its peak, despite maintaining a robust €80 billion order book and strong revenue growth. The company's valuation has compressed to sector levels, with a deeply discounted PEG ratio of 0.4x, indicating both risks and potential upside. Key risks include possible NATO spending cuts if peace returns to Ukraine and execution risks on large orders expected in late 2026. The analyst maintains a Buy rating with a €2,000 price target, citing long-term defense spending growth and Rheinmetall's leading position in the sector.
Rheinmetall's stock has fallen 48% from its peak, a notable decline amid its €80 billion order book and sector valuation shifts. For readers following Industrials, here is Pluang's market snapshot as of Sep 18, 2026 15:21 WIB: out of 76 priced US Industrials stocks, 55 rose and 17 fell. Notable movers include LUV at USD 40.75 with a 1-day change of +1.02%, DAL at USD 80.20 with a 1-day change of +0.97%, and PLUG at USD 2.14 with a 1-day change of +0.94%.
Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...
Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...
Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...
Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...
Barclays lowered its price target for Lennar Corporation to $70 from a higher level, citing a 52% drop in Q3 net earnings to $284 million and an 8.6% revenue decline to $8.05 billion. The homebuilder faces headwinds from rising mortgage rates and wea...
